triiodothyronine has been researched along with ST Elevated Myocardial Infarction in 4 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A total of 1270 patients with STEMI treated with percutaneous coronary intervention (PCI) were consecutively enrolled in our study." | 1.72 | The Association of Thyroid Hormones With Cardiogenic Shock and Prognosis in Patients with ST Segment Elevation Myocardial Infarction (STEMI) Treated with Primary PCI. ( Luo, S; Shen, J; Wang, L; Xiang, J; Xiang, Z; Xue, Y; Zhou, W; Zhu, Y, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xue, Y | 1 |
| Zhu, Y | 1 |
| Shen, J | 1 |
| Zhou, W | 1 |
| Xiang, J | 1 |
| Xiang, Z | 1 |
| Wang, L | 1 |
| Luo, S | 1 |
| Chang, X | 1 |
| Zhang, S | 1 |
| Zhang, M | 1 |
| Wang, H | 1 |
| Fan, C | 1 |
| Gu, Y | 1 |
| Wei, J | 1 |
| Qiu, C | 1 |
| Pingitore, A | 1 |
| Mastorci, F | 1 |
| Piaggi, P | 1 |
| Aquaro, GD | 1 |
| Molinaro, S | 1 |
| Ravani, M | 1 |
| De Caterina, A | 1 |
| Trianni, G | 1 |
| Ndreu, R | 1 |
| Berti, S | 1 |
| Vassalle, C | 1 |
| Iervasi, G | 1 |
| Jankauskienė, E | 1 |
| Orda, P | 1 |
| Barauskienė, G | 1 |
| Mickuvienė, N | 1 |
| Brožaitienė, J | 1 |
| Vaškelytė, JJ | 1 |
| Bunevičius, R | 1 |
1 trial available for triiodothyronine and ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
Usefulness of Triiodothyronine Replacement Therapy in Patients With ST Elevation Myocardial Infarction and Borderline/Reduced Triiodothyronine Levels (from the THIRST Study).
Topics: Adult; Aged; Biomarkers; Coronary Angiography; Dose-Response Relationship, Drug; Echocardiography; F | 2019 |
3 other studies available for triiodothyronine and ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
The Association of Thyroid Hormones With Cardiogenic Shock and Prognosis in Patients with ST Segment Elevation Myocardial Infarction (STEMI) Treated with Primary PCI.
Topics: Humans; Percutaneous Coronary Intervention; Prognosis; Shock, Cardiogenic; ST Elevation Myocardial I | 2022 |
Free triiodothyronine and global registry of acute coronary events risk score on predicting long-term major adverse cardiac events in STEMI patients undergoing primary PCI.
Topics: Aged; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Percutaneous Coronary Intervention; | 2018 |
Relationship between left ventricular mechanics and low free triiodothyronine levels after myocardial infarction: a prospective study.
Topics: Area Under Curve; Biomarkers; Cohort Studies; Echocardiography; Female; Follow-Up Studies; Hospitals | 2016 |